Stocks Health care MNOV

NASDAQ · Health care

Medicinova Inc (MNOV)

It posted a net loss of $10.8M. In fiscal 2025 capital spending exceeded operating cash flow by $9.8M. At June 30, 2026 it held $25.4M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.

Watch MNOV in 60 seconds

Follow MNOV

Free, no password. An email when MNOV files with the SEC.

Key facts about Medicinova Inc

Net worth

Medicinova Inc has a market value (market cap) of $72.4M at the latest share price, and shareholders' equity of $37.3M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Revenue and profit

In fiscal 2025 revenue was $409.7K (-59.0% year on year), with a net loss of $12M.

Cash flow

In fiscal 2025 operations used $9.8M of cash.

Latest report

The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 13, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR

Next earnings report

Medicinova Inc's next report is expected around November 11, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

What Medicinova Inc does

Medicinova Inc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker MNOV.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Where MNOV ranks in Health care

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Medicinova Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. September 29, 2026
   Activist stake changed SCHEDULE 13D/A
2. September 28, 2026
   Material agreement8-KMediciNova entered into a lease amendment extending its office lease through April 30, 2030.
3. September 2, 2026
   Material agreement ended 8-K
4. August 19, 2026
   Executive or director change 8-K
5. August 13, 2026
   Quarterly report 10-Q · period to June 30, 2026Revenue rose 241% to $458.4K versus the same quarter last year; diluted EPS -$0.05 versus -$0.07.
6. June 24, 2026
   Shareholder vote results 8-K
7. May 14, 2026
   Quarterly report 10-Q · period to March 31, 2026Revenue was $187K; diluted EPS -$0.05 versus -$0.06.
8. April 29, 2026
   Annual report to shareholders ARS
9. April 29, 2026
   Additional proxy material DEFA14A
10. April 29, 2026
    Proxy statement DEF 14A

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 29, 2026. Insider transactions on SEC

Insider trades

What the people running Medicinova Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders sold $1.7M worth of shares in the last 90 days and bought none on the open market.

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns MNOV

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

1 insiders reported holding 4,862,047 shares in total, about $7.1M at the last price.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about MNOV

What does Medicinova Inc do?

Medicinova Inc is a company in the Health care sector, listed on NASDAQ as MNOV. Its shares trade on NASDAQ under the ticker MNOV.

What is Medicinova Inc's net worth?

Medicinova Inc has a market value (market cap) of $72.4M at the latest share price, and shareholders' equity of $37.3M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Medicinova Inc profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $10.8M.

When did Medicinova Inc last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the activist stake changed from September 29, 2026.

When is Medicinova Inc's next earnings report?

Medicinova Inc's next report is expected around November 11, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare MNOV with

Compare MNOV with any company

Follow MNOV

Get an email when Medicinova Inc files with the SEC: results, executive changes, material agreements and annual reports.

Follow MNOV

Free, no password. An email when MNOV files with the SEC.

Where the numbers come from

Financial figures are the values Medicinova Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.